Yarbrough Capital’s Bio-Techne TECH Stock Holding History

Yarbrough Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,846	Closed	-$344K	–	143
2025 Q4	$344K	Buy	+5,846	New	+$355K	0.01%	141

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Yarbrough Capital's TECH Position: Q1 2026 in Review

Yarbrough Capital sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 5,846 shares — an estimated $344K sold.

Yarbrough Capital first reported a position in TECH in Q4 2025 and held it in 1 quarter. The position peaked at $344K in Q4 2025. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Yarbrough Capital reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
Yarbrough Capital sold 5,846 Bio-Techne shares in Q1 2026, an estimated $344K.
Yarbrough Capital first reported a position in Bio-Techne in Q4 2025 and held it in 1 quarter.
Yarbrough Capital's Bio-Techne position peaked at $344K in Q4 2025.
584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Yarbrough Capital's 13F filing for Q1 2026, filed 14 Apr 2026.